Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

This Cheap Stock Is Making Billions in Biotech


Novavax (NASDAQ: NVAX) is a leading vaccine maker that has already won authorizations in many countries worldwide. In this Motley Fool Live segment from "The Pharma & Biotech Show," recorded on March 23, Fool.com contributors Taylor Carmichael and Keith Speights discuss why they're bullish on Novavax now. 

Continue reading


Source Fool.com

Like: 0
Share

Comments